Asthma and Respiratory Foundation NZ
Menu
Donate
Asthma and Respiratory Foundation NZ
In this section
Filter by topic:
All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough:

Akio Niimi, Junpei Saito, Tadashi Kamei, Masaharu Shinkai, Hiroyuki Ishihara, Mitsuaki Machida and Sayaka Miyazaki

2 June, 2022

NZ Respiratory Research Review Issue 203

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden:

Yanina Balabanova, Bahman Farahmand, Hans Garmo, Pär Stattin, Gunnar Brobert

23 May, 2022

NZ Respiratory Research Review Issue 202

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles:

Simon Y. Graeber, Diane M. Renz, Mirjam Stahl, Sophia T. Pallenberg, Olaf Sommerburg, Lutz Naehrlich, Julian Berges, Martha Dohna, Felix C. Ringshausen, Felix Doellinger, Constanze Vitzthum, Jobst Röhmel, Christine Allomba, Susanne Hämmerling, Sandra Barth, Claudia Rückes-Nilges, Mark O. Wielpütz, Gesine Hansen, Jens Vogel-Claussen, Burkhard Tümmler, Marcus A. Mall, and Anna-Maria Dittrich

10 May, 2022

NZ Respiratory Research Review Issue 203

Tuberculosis and COVID-19 co-infection: description of the global cohort:

The TB/COVID-19 Global Study Group. Corresponding author: Giovanni Battista Migliori

24 March, 2022

NZ Respiratory Research Review Issue 199

The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial:

rof Harm A W M Tiddens, MD Yuxin Chen, MS Eleni-Rosalina Andrinopoulou, PhD Prof Stephanie D Davis, MD Prof Margaret Rosenfeld, MD Prof Felix Ratjen, MD et al.

11 March, 2022

NZ Respiratory Research Review Issue 203

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial:

Veronique De Jager, Nikhil Gupte, Silvia Nunes, Grace L. Barnes, Rob Christiaan van Wijk, Joni Mostert, Susan E. Dorman, Ahmed A. Abulfathi, Caryn M. Upton, Alan Faraj, Eric L. Nuermberger, Gyanu Lamichhane, Elin M. Svensson, Ulrika S. H. Simonsson, Andreas H. Diacon, Kelly E. Dooley, and the COMRADE Study Team

8 March, 2022

NZ Respiratory Research Review Issue 199

BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension:

Breanne E. McCarthy, MD Robyn L. McClelland, PhD Dina H. Appleby, MS Jude S. Moutchia, MD Jasleen K. Minhas, MD Jeff Min, MD Jeremy A. Mazurek, MD K. Akaya Smith, MD Jason S. Fritz, MD Steven C. Pugliese, MD Ryan J. Urbanowicz, PhD John H. Holmes, PhD Harold I. Palevsky, MD Steven M. Kawut, MD Nadine Al-Naamani, MD

2 March, 2022

NZ Respiratory Research Review Issue 202

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study):

Aliasgar Esmail, Suzette Oelofse, Carl Lombard, Rubeshan Perumal, Linda Mbuthini, Akhter Goolam Mahomed, Ebrahim Variava, John Black, Patrick Oluboyo, Nelile Gwentshu, Eric Ngam, Tertius Ackerman, Linde Marais, Lynelle Mottay, Stuart Meier, Anil Pooran, Michele Tomasicchio, Julian Te Riele, Brigitta Derendinger, Norbert Ndjeka, Gary Maartens, Robin Warren, Neil Martinson, and Keertan Dheda

17 February, 2022

NZ Respiratory Research Review Issue 199

Alveolar crystal burden in stone workers with artificial stone silicosis:

Simon H. Apte,Maxine E. Tan,Viviana P. Lutzky,Tharushi A. De Silva,Andreas Fiene,Justin Hundloe,David Deller,Clair Sullivan,Peter T. Bell,Daniel C. Chambers

17 February, 2022

NZ Respiratory Research Review Issue 201

Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism:

David Jiménez, Carmen Rodríguez, Francisco León, Luis Jara-Palomares, Raquel López-Reyes, Pedro Ruiz-Artacho, Teresa Elías, Remedios Otero, Alberto García-Ortega, Agustina Rivas-Guerrero, Jaime Abelaira, Sonia Jiménez, Alfonso Muriel, Raquel Morillo, Deisy Barrios, Raphael Le Mao, Roger D. Yusen, Behnood Bikdeli, Manuel Monreal, and José Luis Lobo for the IPEP investigators

10 February, 2022

NZ Respiratory Research Review Issue 202